ArticleCancer immunology research2017
Angiopoietin-2 as a Biomarker and Target for Immune Checkpoint Therapy.
Xinqi Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
108 papers cite itlatest 60 shown
this paperpooled ittrialcites it